Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy.
Zhang Z, Cheng L, Li J, Qiao Q, Karki A, Allison DB, Shaker N, Li K, Utturkar SM, Atallah Lanman NM, Rao X, Rychahou P, He D, Konieczny SF, Wang C, Shao Q, Evers BM, Liu X.
Zhang Z, et al. Among authors: liu x.
Cancer Res. 2022 Oct 4;82(19):3532-3548. doi: 10.1158/0008-5472.CAN-22-0018.
Cancer Res. 2022.
PMID: 35950917
Free PMC article.